FDA Okays Tablet Version of Acalabrutinib for All Indications FDA Okays Tablet Version of Acalabrutinib for All Indications

The new formulation can be taken with proton pump inhibitors and other gastric acid reducers.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news